Skip to main content
. 2013 Apr 23;8(4):e60369. doi: 10.1371/journal.pone.0060369

Figure 5. miR-219-2-3p inhibits activation of p-ERK1/2.

Figure 5

(A) MGC-803 and HGC-27 cells untreated and transfected with scrambled or miR-219-2-3p mimics were subjected to western blot analysis of phosphorylated ERK1/2, total ERK1/2 and GAPDH (as a loading control). The data shown is representative of three individual western blot analyses. (B) The candidate onco-targets of miR-219-2-3p forecast by TargetScan Release 5.2, and miRDB. (C) Bioinformatically and functionally implicated miR-219-2-3p in GC.